The SCICONX Journal of Vaccine and Immunology (JVI) is committed to maintaining the highest standards of scholarly publishing through a transparent, ethical, and academically independent editorial policy. The journal’s editorial practices are designed to ensure that all published content is scientifically sound, ethically conducted, and relevant to the advancement of vaccine science and immunological research.
Editorial decisions are guided solely by academic merit and are free from commercial, institutional, or personal influence.
Editorial Independence
This journal operates with full editorial independence. The Editor-in-Chief and editorial team have complete authority over the editorial content of the journal, including manuscript selection, peer review outcomes, and publication decisions. The publisher does not interfere with editorial decision-making or influence acceptance or rejection of manuscripts.
This independence safeguards the credibility of the journal and ensures trust among authors, reviewers, and readers.
Roles and Responsibilities
Editor-in-Chief
The Editor-in-Chief provides strategic leadership and is responsible for:
Associate Editors and Section Editors
Associate and Section Editors support the editorial process by:
Editorial Board Members
Editorial Board members provide subject-matter expertise, support peer review activities, and advise on journal development and emerging research areas.
Manuscript Evaluation and Decision Criteria
All submitted manuscripts are evaluated based on the following core criteria:
Editorial decisions may include acceptance, minor revision, major revision, or rejection. Decisions are communicated clearly and respectfully to authors.
Peer Review Integrity
The journal employs a structured peer review process to ensure objectivity and fairness. Editors are responsible for:
The editorial team reserves the right to seek additional reviews or editorial opinions when necessary.
Ethical Standards and Misconduct
This journal maintains a zero-tolerance approach to unethical publishing practices. The editorial team actively monitors for:
Suspected misconduct is handled confidentially and in accordance with established ethical guidelines. Appropriate actions may include manuscript rejection, retraction, or notification of relevant institutions.
Conflicts of Interest
Editors involved in the handling of a manuscript must disclose any conflicts of interest. When a conflict exists, editorial responsibility is reassigned to ensure impartial decision-making.
Transparency and Communication
The editorial office is committed to clear, timely, and professional communication with authors and reviewers. Authors are kept informed of the progress of their manuscripts, and editorial decisions are accompanied by constructive feedback.
Use of Artificial Intelligence
The journal acknowledges the responsible use of artificial intelligence in scholarly publishing. Editors may use AI-assisted tools for administrative or language-related support; however:
Corrections, Retractions, and Updates
The editorial team is responsible for maintaining the integrity of the scholarly record. When necessary, corrections, expressions of concern, or retractions are issued transparently to address significant errors or ethical concerns.
Continuous Improvement
The SCICONX Journal of Vaccine and Immunology regularly reviews and updates its editorial policies to reflect evolving best practices in scholarly publishing. Feedback from authors, reviewers, and editors is welcomed to support continuous improvement.
Commitment to Excellence
Through this editorial policy, the journal reaffirms its commitment to academic integrity, scientific excellence, and responsible dissemination of research in vaccinology and immunological sciences.